Skip to main content

MoneyWorks4Me

Jenburkt Pharmaceuticals informs about board meeting

25 Jan 2020 Evaluate

Jenburkt Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 07/02/2020 to consider and approve unaudited financial results of the Company for the quarter and nine months ended on 31st December, 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1897.80
Dr. Reddys Labs. 1375.85
Cipla 1414.80
Lupin 2016.50
Zydus Lifesciences 1203.65
View more..